The role of nuclear macromolecules in innate immunity

Proceedings of the American Thoracic Society

Volumn 4, Issue 3, 2007, Pages 258-262

  Pisetsky, David S ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; DNA; HMGB1; Innate immunity; Necrosis

Indexed keywords

BACTERIAL DNA; CYTOKINE; DNA; DNA BINDING PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; TOLL LIKE RECEPTOR;

ANTIGEN ANTIBODY COMPLEX; CELL DEATH; CELL FUNCTION; CONFERENCE PAPER; DNA SEQUENCE; GENE TRANSLOCATION; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MACROMOLECULE; NONHUMAN; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; APOPTOSIS; DNA; HMGB1 PROTEIN; HUMANS; IMMUNITY, NATURAL; MACROPHAGES;

EID: 34447117790     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200701-027AW     Document Type: Conference Paper

References (43)

1. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-151.
2. Kotzin BL. Systemic lupus erythematosus. Cell 1996;85:303-306.
3. Pisetsky DS. Antibody responses to DNA in normal immunity and aberrant immunity. Clin Diagn Lab Immunol 1998;5:1-6.
4. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nat Med 2001;7:899-905.
5. Pisetsky DS. Immune activation by bacterial DNA: a new genetic code. Immunity 1996;5:303-310.
6. Wagner H. The immunobiology of the TLR9 subfamily. Trends Immunol 2004;25:381-386.
7. Wu ZQ, Drayton D, Pisetsky DS. Specificity and immunochemical properties of antibodies to bacterial DNAin sera of normal human subjects and patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1997;109:27-31.
8. Pisetsky DS, Drayton D, Wu ZQ. Specificity of antibodies to bacterial DNA in the sera of healthy human subjects and patients with systemic lupus erythematosus (SLE). J Rheum 1999;26:1934-1938.
9. Hamilton KJ, Schett G, Reich CF III, Smolen J, Pisetsky DS. The binding of sera of patients with SLE to bacterial and mammalian DNA. Clin Immunol 2006;118:209-218.
10. Pisetsky DS, Drayton DM. Deficient expression of antibodies for bacterial DNA by patients with systemic lupus erythematosus. Proc Assoc Am Physicians 1997;109:237-244.
11. Gilkeson GS, Ruiz P, Pippen AMM, Alexander AL, Lefkowitz JB, Pisetsky DS. Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J Exp Med 1996;183:1389-1397.
12. Vallin H, Perers A, Alm GV, Rönnblom L. Anti-double stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-α inducer in systemic lupus erythematosus. J Immunol 1999;163:6306-6313.
13. Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity 2003;19:837-847.
14. Rönnblom L, Eloranta M-L, Alm GV. The Type I interferon system in systemic lupus erythematosus. Arthritis Rheum 2006;54:408-420.
15. 1. J Immunol 2000;165:3519-3526.
16. Means TK, Latz E, Hayashi F, Murali MR, Golenbock DT, Luster AD. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 2005;115:407-417.
17. Zhu FG, Reich CF III, Pisetsky DS. Inhibition of murine macrophage nitric oxide production by synthetic oligonucleotides. J Leukoc Biol 2002;71:686-694.
18. Jiang W, Reich CF III, Pisetsky DS. Mechanisms of activation of the RAW264.7 macrophage cell line by transfected mammalian DNA. Cell Immunol 2004;229:31-40.
19. Okabe Y, Kawane K, Akira S, Taniguchi T, Nagata S. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J Exp Med 2005;202:1333-1339.
20. Ishii KJ, Coban C, Kato H, Takahashi K, Torii Y, Takeshita F, Ludwig H, Sutter G, Suzuki K, Hemmi H, et al. takeuchi O, Akira S. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol 2006;7:40-48.
21. Sidransky D. Circulating DNA: what we know and what we need to learn. Ann N Y Acad Sci 2000;906:1-4.
22. Lui YYN, Lo YMD. Circulating DNA in plasma and serum: biology preanalytical issues and diagnostic applications. Clin Chem Lab Med 2002;40:962-968.
23. Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 2005;73:1907-1916.
24. Choi JJ, Reich CF III, Pisetsky DS. Release of DNA from dead and dying lymphocyte and monocytes cell lines in vitro. Scand J Immunol 2004;60:159-166.
25. Choi JJ, Reich CF III, Pisetsky DS. The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells. Immunology 2005;115:55-62.
26. Jiang N, Reich CF III, Pisetsky DS. Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells. Blood 2003;102:2243-2250.
27. Jiang N, Pisetsky DS. The effect of dexamethasone on the generation of plasma DNA from dead and dying cells. Am J Pathol 2004;164:1751-1759.
28. Jiang N, Pisetsky DS. The effect of inflammation on the generation of plasma DNA from dead and dying cells in the peritoneum. J Leukoc Biol 2005;77:296-302.
29. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999;19:5237-5246.
30. Thomas JO. HMG1 and 2: architectural DNA-binding proteins. Biochem Soc Trans 2001;29:395-401.
31. Erlandsson-Harris H, Raucci A. Alarmin(g) news about danger: workshop on innate danger signals and HMGB1. EMBO Rep 2006:7;774-778.
32. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Jiantu C, Frazier A, Yang H, Ivanova S, Borovikova L, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248-251.
33. Andersson U, Wang H, Palmblad K, Aveberger A-C, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000;192:565-570.
34. Müller S, Scaffidi P, Degryse B, Bonaldi T, Ronfani L, Agresti A, Beltrame M, Bianchi ME. The double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J 2001;20:4337-4340.
35. Agnello D, Wang H, Yang H, Tracey KJ, Ghezzi P. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 2002;18:231-236.
36. Park JS, Arcaroli J, Yum H-K, Yang H, Wang H, Yang K-Y, Choe K-H, Strassheim D, Pitts TM, Tracey KJ, et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 2003;284:C870-C879.
37. Kokkola R, Andersson Å, Mullins G, Östberg T, Treutigert C-J, Arnold B, Nawroth P, Andersson U, Harris RA, Harris HE. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 2005;61:1-9.
38. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, Bianchi ME. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003;22:5551-5560.
39. Youn JH, Shin J-S. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol 2006;177:7889-7897.
40. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191-195.
41. Bell CW, Jiang W, Reich CF III, Pisetsky DS. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 2006;291:C1318-C1325.
42. Rouhiainen A, Tumova S, Valmu L, Kalkkinen N, Rauvala H. Analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (Amphoterin). J Leukoc Biol 2007;81:49-58.
43. Böttger M, Vogel F, Platzer M, Kiessling U, Grade K, Strauss M. Condensation of vector DNA by the chromosomal protein HMG1 results in efficient transfection. Biochim Biophys Acta 1988;950:221-228.